Verition Fund Management LLC Compugen LTD Transaction History

Verition Fund Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.88 - $1.31 $652,001 - $970,593	740,911 New	740,911 $689,000
Q2 2021 Aug 16, 2021	SELL	$6.87 - $9.16 $2.64 Million - $3.52 Million	-383,748 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$7.67 - $13.77 $1.99 Million - $3.57 Million	259,083 Added 207.82%	383,748 $3.3 Million
Q4 2020 Feb 16, 2021	BUY	$12.07 - $17.95 $1.5 Million - $2.24 Million	124,665 New	124,665 $1.51 Million
Q3 2020 Nov 16, 2020	SELL	$14.16 - $19.45 $622,827 - $855,508	-43,985 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$6.97 - $17.12 $1.28 Million - $3.14 Million	-183,147 Reduced 80.63%	43,985 $661,000
Q1 2020 May 15, 2020	BUY	$5.79 - $11.83 $1.32 Million - $2.69 Million	227,132 New	227,132 $1.65 Million

13.3M

191K

135K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $142M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.